Delivery Order SPE2DB24D1104-SPE2DB25FXZZ8

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,380.41, is for the supply of Enalapril 1 mg/ml oral solution, a cardiovascular medication, to support military healthcare programs. The contract has a period of performance through January 7, 2025 and utilizes a Firm Fixed Price pricing structure. This award is associated with a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,865.64 Firm Fixed Price delivery order is for the supply of Enalapril 1 mg/ml oral solution in 150ml bottles, with a period of performance through October 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $10,418.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Enalapril 1 mg/ml oral solution, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of February 6, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside and represents...
This is a $5,028.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567631557 - ENALAPRIL 1 MG/ML ORAL SOLN 150ML, a generic cardiovascular medication. The order has a period of performance through March 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the provision of ENALAPRIL 1 MG/ML ORAL SOLN 150ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with a potential value of $1,563.96 and a completion date of February 26, 2024. No set-aside designation was used...
The Defense Logistics Agency awarded a $351.84 delivery order to Amerisourcebergen Drug Corp for 2.5 mg/2 ml vials of enalaprilat. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a firm fixed price contract ending on September 22, 2023. The Defense Logistics Agency supports Department of Defense procurement programs by fulfilling medical material requirements, among other responsibilities. No...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,410.49 and a completion date of June 17, 2024. It is for the delivery of AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a pharmaceutical product, and is a firm fixed-price contract type. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
Amerisourcebergen Drug Corp has been awarded a delivery order against an indefinite-delivery/indefinite-quantity contract vehicle held by the Defense Logistics Agency. This firm fixed price award is for 1,000 tablets of 5 mg enalapril maleate to be delivered by October 10, 2023. With a potential value of zero dollars, the delivery order was awarded non-competitively on October 6, 2023 to fulfill requirements for the Agency's pharmaceutical procurement programs. Performance will occur at the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,531.89 firm-fixed-price contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets, with a performance period through January 2, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXZZ8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Enalapril 1 mg/ml oral solution in 150 ml bottles, with a ceiling value of $13,356.60 and a period of performance through April 2025. The contract is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 7/18/25, 10:08 AM